nach oben

12.01.2021 | Ausgabe 3/2021

Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity

Zeitschrift:: Cardiovascular Toxicology > Ausgabe 3/2021

Autoren:: Ling He, Fuxiang Liu, Juxiang Li

» Jetzt Zugang zum Volltext erhalten

Wichtige Hinweise

Handling Editor: Rajiv Janardhanan

Ling He and Fuxiang Liu are co-first author of this work.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Doxorubicin (DOX) is the most effective and extensively used treatment for many tumors. However, its clinical use is hampered by its cardiotoxicity. DOX-induced mitochondrial dysfunction, which causes reactive oxygen species (ROS) generation, cardiomyocyte death, bioenergetic failure, and decreased cardiac function, is a very important mechanism of cardiotoxicity. These cellular processes are all linked by mitochondrial sirtuins (SIRT3–SIRT4). Mitochondrial sirtuins preserve mitochondrial function by increasing mitochondrial metabolism, inhibiting ROS generation by activating the antioxidant enzyme manganese-dependent superoxide dismutase (MnSOD), decreasing apoptosis by activating the forkhead homeobox type O (FOXO) and P53 pathways, and increasing autophagy through AMP-activated protein kinase (AMPK)/mTOR signaling. Thus, sirtuins function at the control point of many mechanisms involved in DOX-induced cardiotoxicity. In this review, we focus on the role of mitochondrial sirtuins in mitochondrial biology and DOX-induced cardiotoxicity. A further aim is to highlight other mitochondrial processes, such as autophagy (mitophagy) and mitochondrial quality control (MQC), for which the effect of mitochondrial sirtuins on cardiotoxicity is unknown.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

★ PREMIUM-INHALT

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt gratis testen * Jetzt kaufen

Sie können e.Med Interdisziplinär 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ¹

Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52, 1213–1225. PubMed

Bernstein, D. (2018). Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking? Circulation Research, 122, 188–190. PubMedPubMedCentral

Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014). Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Medicinal Research Reviews, 34, 106–135. PubMed

Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., & Zhao, F., et al. (2019). Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy. The FASEB Journal, 33, 11096–11108. PubMedPubMedCentral

Anker, M.S., Hadzibegovic, S., Lena, A., Belenkov, Y., Bergler-Klein, J., de Boer, R.A., Farmakis, D., von Haehling, S., Iakobishvili, Z., Maack, C., Pudil, R., Skouri, H., Cohen-Solal, A., Tocchetti, C.G., Coats, A.J.S., Seferovic, P.M., & Lyon, A.R. and Heart Failure Association Cardio-Oncology Study Group of the European Society of, C. (2019). Recent advances in cardio-oncology: a report from the “Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019.” ESC Heart Fail, 6, 1140–1148.

Renu, K., & V, G.A., P, B.T. and Arunachalam, S. . (2018). Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. European Journal of Pharmacology, 818, 241–253. PubMed

Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L., Lyu, Y., Liu, L., & Yeh, E. T. H. (2012). Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nature Medicine, 18, 1639–1642. PubMed

Ma, W., Wei, S., Zhang, B., & Li, W. (2020). Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity. Frontiers in Cell and Developmental Biology, 8, 434. PubMedPubMedCentral

Tadokoro, T., Ikeda, M., Ide, T., Deguchi, H., Ikeda, S., & Okabe, K., et al. (2020). Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight, 5, e132747. PubMedCentral

10.

Jenelle Govender BL, Erna Marais, Anna Mart Engelbrecht (2014) Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity a review of the protective role of melatonin. Journal of Pineal Research. 57: 367–380

11.

Carrico, C. M., He, J. G., Gibson, W., Verdin, B. W., & E. . (2018). The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications. Cell Metabolism, 27, 497–512. PubMedPubMedCentral

12.

Bergmann, L.L., Alexander Bross, Christoph Altinoluk-Hambüchen, Simone Fey, Iris Overbeck, Nina Stefanski, Anja Wiek, Constanze, Kefalas, A., Verhülsdonk, P., Mielke, C., Sohn, D., Stühler, K., Hanenberg, H., Jänicke, R.U., Scheller, J., Reichert, A.S., Ahmadian, M.R. and Piekorz, R.P. (2020). Subcellular localization and mitotic interactome analyses identify SIRT4 as a centrosomally localized and microtubule associated protein. Cells 9: 1950

13.

Du, Y. H., Qu, H., Wang, S., & J., Hua, C., Zhang, J., Wei, P., He, X., Hao, J., Liu, P., Yang, F., Li, T. and Wei, T. . (2018). SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob mice. EBioMedicine, 36, 347–357. PubMedPubMedCentral

14.

Xiaoqiang Tang, X.-F.C., Chen, H.-Z., & Liu, D.-P. (2017). Mitochondrial Sirtuins in cardiometabolic diseases. Clin Sci (Lond), 131, 2063–2078.

15.

van de Ven, R. A. H. S., Haigis, D., & M. C. . (2017). Mitochondrial Sirtuins and Molecular Mechanisms of Aging. Trends Mol Med, 23, 320–331. PubMedPubMedCentral

16.

Du Qiong, B. Z., Zha, Q., & Bo, Yu. (2017). Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3. Am J Transl Res., 9(7), 3360–3373.

17.

Pillai, V. B. B., Sharp, S., Fang, W., Kim, Y. H., Gupta, G., & Samant, M., et al. (2016). Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice. Am J Physiol Heart Circ Physiol, 310, H962-972. PubMedPubMedCentral

18.

Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., & Lombard, D. B., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464, 121–125. PubMedPubMedCentral

19.

Bong-Hyun Ahn, H.-S.K., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C.-X., & Finkel, T. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. PNAS, 105(38), 14447–14452. PubMed

20.

Liu, L., Xie, B., Fan, M., Candas-Green, D., Jiang, J. X., & Wei, R., et al. (2020). Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade. Developmental Cell, 52(196–209), e199.

21.

Qiao, Y., Xu, L., Tao, X., Yin, L., Qi, Y., & Xu, Y., et al. (2018). Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation. Toxicology Letters, 284, 37–45. PubMed

22.

Yang, Y., Wang, W., Xiong, Z., Kong, J., Qiu, Y., Shen, F., & Huang, Z. (2016). Activation of SIRT3 attenuates triptolide-induced toxicity through closing mitochondrial permeability transition pore in cardiomyocytes. Toxicology in Vitro, 34, 128–137. PubMed

23.

Sadhukhan, S., Liu, X., Ryu, D., Nelson, O. D., Stupinski, J. A., & Li, Z., et al. (2016). Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. Proc Natl Acad Sci U S A, 113, 4320–4325. PubMedPubMedCentral

24.

Kane, A. E., & Sinclair, D. A. (2018). Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases. Circulation Research, 123, 868–885. PubMedPubMedCentral

25.

Guo, L., Zhou, S. R., Wei, X. B., Liu, Y., Chang, X. X., & Liu, Y., et al. (2016). Acetylation of Mitochondrial Trifunctional Protein alpha-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease. Molecular and Cellular Biology, 36, 2553–2567. PubMedPubMedCentral

26.

Laurent, G., German, N. J., Saha, A. K., de Boer, V. C., Davies, M., & Koves, T. R., et al. (2013). SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Molecular Cell, 50, 686–698. PubMedPubMedCentral

27.

Gu, L., & Z.Y.L.X.T.X.L.B., Li Y. . (2020). Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene, 39, 2437–2449. PubMed

28.

Chen, B., Zang, W., Wang, J., Huang, Y., He, Y., & Yan, L., et al. (2015). The chemical biology of sirtuins. Chemical Society Reviews, 44, 5246–5264. PubMed

29.

Shimazu, T., Hirschey, M. D., & Hua, L., Dittenhafer-Reed, K. E., Schwer, B., Lombard, D. B., et al. (2010). SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metabolism, 12, 654–661. PubMedPubMedCentral

30.

Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., & Danielson, S. R., et al. (2013). SIRT5 Regulates the Mitochondrial Lysine Succinylome and Metabolic Networks. Cell Metabolism, 18, 920–933. PubMedPubMedCentral

31.

Dienel, G. A. (2019). Brain Glucose Metabolism: Integration of Energetics with Function. Physiological Reviews, 99, 949–1045. PubMed

32.

Fan, J., Shan, C., Kang, H.-B., Elf, S., Xie, J., & Tucker, M., et al. (2014). Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex. Molecular Cell, 53, 534–548. PubMedPubMedCentral

33.

Ozden, O., Park, S.-H., Wagner, B. A., Yong Song, H., Zhu, Y., & Vassilopoulos, A., et al. (2014). SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radical Biology and Medicine, 76, 163–172. PubMed

34.

Cui, Y., Qin, L., Wu, J., Qu, X., Hou, C., & Sun, W., et al. (2015). SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells. PLoS ONE, 10, e0129834. PubMedPubMedCentral

35.

Fujino, T. K., Ishikawa, J., Morikawa, M., Yamamoto, K., & T. T. . (2001). Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. Journal of Biological Chemistry, 276, 11420–11426.

36.

Mathias, R. A., Greco, T. M., Oberstein, A., Budayeva, H. G., Chakrabarti, R., & Rowland, E. A., et al. (2014). Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell, 159, 1615–1625. PubMedPubMedCentral

37.

Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., & Leeuwenburgh, C., et al. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell, 143, 802–812. PubMedPubMedCentral

38.

Sundaresan, N. R., Gupta, M., Kim, G., Rajamohan, S. B., Isbatan, A., & Gupta, M. P. (2009). Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest, 119, 2758–2771. PubMedPubMedCentral

39.

Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., & Lombard, D., et al. (2011). Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci U S A, 108, 14608–14613. PubMedPubMedCentral

40.

Wang, Z. S., Wang, R., Chen, G., Li, Z., Zhao, Y., & Liu, Y., et al. (2020). SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury. Redox Biol, 28, 101343. PubMed

41.

Liu, B., Che, W., Zheng, C., Liu, W., Wen, J., & Fu, H., et al. (2013). SIRT5: a safeguard against oxidative stress-induced apoptosis in cardiomyocytes. Cellular Physiology and Biochemistry, 32, 1050–1059. PubMed

42.

Zhou, L., Wang, F., Sun, R., Chen, X., Zhang, M., & Xu, Q., et al. (2016). SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense. EMBO Reports, 17, 811–822. PubMedPubMedCentral

43.

Ling Liu, Q. W., Zhao, B., Qian, Wu., & Wang, P. (2019). Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway. European Journal of Pharmacology, 858, 172520. PubMed

44.

Luo, Y. X., Tang, X., An, X. Z., Xie, X. M., Chen, X. F., & Zhao, X., et al. (2017). SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. European Heart Journal, 38, 1389–1398. PubMed

45.

Jianxia Shi, Q. W., Li, H., & Huang, Q. (2017). SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis. Exp Ther Med, 13, 342–348.

46.

Liu, M., Wang, Z., Ren, M., Yang, X., Liu, B., & Qi, H., et al. (2019). SIRT4 regulates PTEN stability through IDE in response to cellular stresses. The FASEB Journal, 33, 5535–5547. PubMed

47.

Green, D. R., Galluzzi, L., & Kroemer, G. (2014). Metabolic control of cell death. Science, 345, 1250256–1250256. PubMedPubMedCentral

48.

Westermann, B. (2010). Mitochondrial fusion and fission in cell life and death. Nature Reviews Molecular Cell Biology, 11, 872–884. PubMed

49.

Samant, S. A., Zhang, H. J., Hong, Z., Pillai, V. B., Sundaresan, N. R., & Wolfgeher, D., et al. (2014). SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Molecular and Cellular Biology, 34, 807–819. PubMedPubMedCentral

50.

Lang, A., Anand, R., Altinoluk-Hambuchen, S., Ezzahoini, H., Stefanski, A., & Iram, A., et al. (2017). SIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy. Aging (Albany NY), 9, 2163–2189.

51.

Pena-Blanco, A., Haschka, M.D., Jenner, A., Zuleger, T., Proikas-Cezanne, T., Villunger, A. and Garcia-Saez, A.J. (2020). Drp1 modulates mitochondrial stress responses to mitotic arrest. Cell Death Differ. doi: https://doi.org/10.1038/s41418-020-0527-y

52.

Karbowski, R.J.Y. (2005). Mitochondrial fission in apoptosis. nature VOLUME 6.

53.

Morigi, M., Perico, L., Rota, C., Longaretti, L., Conti, S., & Rottoli, D., et al. (2015). Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest, 125, 715–726. PubMedPubMedCentral

54.

Fu, L., Dong, Q., He, J., Wang, X., Xing, J., & Wang, E., et al. (2017). SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway. Oncogene, 36, 2724–2736. PubMed

55.

Laurent, G., de Boer, V. C., Finley, L. W., Sweeney, M., Lu, H., & Schug, T. T., et al. (2013). SIRT4 represses peroxisome proliferator-activated receptor alpha activity to suppress hepatic fat oxidation. Molecular and Cellular Biology, 33, 4552–4561. PubMedPubMedCentral

56.

Guedouari, H., Daigle, T., Scorrano, L., & Hebert-Chatelain, E. (2017). Sirtuin 5 protects mitochondria from fragmentation and degradation during starvation. Biochim Biophys Acta Mol Cell Res, 1864, 169–176. PubMed

57.

Buler, M., Aatsinki, S. M., Izzi, V., Uusimaa, J., & Hakkola, J. (2014). SIRT5 is under the control of PGC-1alpha and AMPK and is involved in regulation of mitochondrial energy metabolism. The FASEB Journal, 28, 3225–3237. PubMed

58.

X, Z., M, C., X, Z., J, Y., H, D., L, Y. and MT, M. . (2014). Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells. Cell death & disease, 5, e1576.

59.

Lang, A., Anand, R., Altinoluk-Hambuchen, S., Ezzahoini, H., Stefanski, A., & Iram, A., et al. (2018). SIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy. Aging (Albany NY), 10, 2536c.

60.

Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. R., & Ait-Oudhia, S. (2019). Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring. Molecular Pharmacology, 96, 219–232. PubMed

61.

Sokpolove, P. M. (1994). Interaction of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity. Int J Biochen, 26, 1341–1350.

62.

Kostler, H., Landschutz, W., Koeppe, S., Seyfarth, T., Lipke, C., & Sandstede, J., et al. (2006). Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magnetic Resonance in Medicine, 56, 907–911. PubMed

63.

Beer, M., Seyfarth, T., Sandstede, J., Landschütz, W., Lipke, C., & Köstler, H., et al. (2002). Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. Journal of the American College of Cardiology, 40, 1267–1274. PubMed

64.

Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., & Naga Prasad, S. V., et al. (2014). Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest, 124, 617–630. PubMedPubMedCentral

65.

Eidenschink, A. B., G, S., Muller-Weihrich, S., & Stern, H. (2000). Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood. Cardiology Young, 10, 610–617.

66.

Kerstin, N. T., & Tyler, J. D. (2020). The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-020-06941-x. CrossRef

67.

Cimen, H., Han, M. J., Yang, Y., Tong, Q., Koc, H., & Koc, E. C. (2010). Regulation of Succinate Dehydrogenase Activity by SIRT3 in Mammalian Mitochondria. Biochemistry, 49, 304–311. PubMedPubMedCentral

68.

Linh Ho, A.S.T., Kushal Kr Banerjee, Suji George, Wei Lin, Shaunak Deota, Asish K. Saha, Ken Nakamura, Philipp Gut, Eric Verdin, and Ullas Kolthur‐Seetharam. (2013). SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK. AGING doi: https://doi.org/10.18632/aging.100616

69.

Guangwei Zeng, H. L., & Wang, H. (2018). Amelioration of myocardial ischemia-reperfusion injury by SIRT4 involves mitochondrial protection and reduced apoptosis. Biochemical and Biophysical Research Communications, 502, 15–21. PubMed

70.

Yang, W., Nagasawa, K., Munch, C., Xu, Y., Satterstrom, K., & Jeong, S., et al. (2016). Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization. Cell, 167(985–1000), e1021.

71.

Zhang, T. L., Shen, J., Tong, S., Ma, Q., Lin, X., & L. . (2020). SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death and Differentiation, 27, 329–344. PubMed

72.

Jenelle Govender, B. L., Marais, E., & Engelbrecht, A.-M. (2014). Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. Journal of pineal research, 57, 367–380. PubMed

73.

Shigetoshi Wakasugi, A. J. F., Babich, J. W., Callahan, R. J., Elmaleh, D. R., Wilkinson, R., & Wffliam Strauss, H. (1993). Myocardial Substrate Utilization and Left Ventricular Function in Adriamycin Cardiomyopathy. Journal of Nuclear Medicine, 34, 1529–1535.

74.

Alessandra Bordoni, P.B., Silvana Hrelia. (1999). The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes. Biochimica et Biophysica Acta 1440:100–106.

75.

Natasha Iliskovic, T. L., Khaper, N., Palace, V., & Singal, P. K. (1998). Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Molecular and Cellular Biochemistry, 188, 161–166.

76.

Arunachalam, S., Tirupathi Pichiah, P. B., & Achiraman, S. (2013). Doxorubicin treatment inhibits PPARgamma and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models. FEBS Letters, 587, 105–110. PubMed

77.

Ghosh, G., De, K., Maity, S., Bandyopadhyay, D., Bhattacharya, S., Reiter, R. J., & Bandyopadhyay, A. (2007). Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. Journal of Pineal Research, 42, 71–82. PubMed

78.

Lai, Y. C., Tabima, D. M., Dube, J. J., Hughan, K. S., Vanderpool, R. R., & Goncharov, D. A., et al. (2016). SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Circulation, 133, 717–731. PubMedPubMedCentral

79.

Pillai, V. B., Sundaresan, N. R., Kim, G., Gupta, M., Rajamohan, S. B., & Pillai, J. B., et al. (2010). Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. Journal of Biological Chemistry, 285, 3133–3144.

80.

Fan, G.-C., Zeng, H., Li, L., & Chen, J.-X. (2014). Loss of Sirt3 Limits Bone Marrow Cell-Mediated Angiogenesis and Cardiac Repair in Post-Myocardial Infarction. PLoS ONE, 9, e107011.

81.

Kalyanaraman, B. (2020). Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree? Redox Biol, 29, 101394. PubMed

82.

Doroshow, J. H. (1983). Anthracycline Antibiotic-stimulated Superoxide, Hydrogen Peroxide, and Hydroxyl Radical Production by NADH Dehydrogenase1. Cancer Research, 43, 4543–4551. PubMed

83.

Kaiserova, H., Simunek, T., Sterba, M., den Hartog, G. J., Schroterova, L., & Popelova, O., et al. (2007). New iron chelators in anthracycline-induced cardiotoxicity. Cardiovascular Toxicology, 7, 145–150. PubMed

84.

Timao Li, I. D., & Singal, P. K. (2002). Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Molecular and Cellular Biochemistry, 2(232), 19–26.

85.

Wallace, K. B. (2003). Doxorubicin-Induced Cardiac Mitochondrionopathy. Pharmacology & Toxicology, 93, 105–115.

86.

Koleini, N., Nickel, B. E., Edel, A. L., Fandrich, R. R., Ravandi, A., & Kardami, E. (2019). Oxidized phospholipids in Doxorubicin-induced cardiotoxicity. Chemico-Biological Interactions, 303, 35–39. PubMed

87.

Aust, C. T. S. (1986). Release of Iron from Ferritin by Cardiotoxic Anthracycline Antibiotics. Archives Biochemistry Biophysics, 248, 68–689.

88.

Giorgio Minottl, G. C., & MontI, E. (1999). Role of iron in anthracycline cardiotoxicity: new tunes for an old song? The FASEB Journal, 13, 199–212.

89.

Castillo, E. C. M., & J. A., Chapoy-Villanueva, H., Silva-Platas, C., Trevino-Saldana, N. Guerrero-Beltran, C. E. Bernal-Ramirez, J. Torres-Quintanilla, A. Garcia, N. Youker, K. Torre-Amione, G. & Garcia-Rivas, G. . (2019). Mitochondrial Hyperacetylation in the Failing Hearts of Obese Patients Mediated Partly by a Reduction in SIRT3: The Involvement of the Mitochondrial Permeability Transition Pore. Cellular Physiology and Biochemistry, 53, 465–479. PubMed

90.

J, G., B, L., E, M. and AM, E. . (2014). Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. Journal of pineal research, 57, 367–380.

91.

Cheung, K. G., & Q.T., Laura K. Cole‡, Bo Xiang, Keyun Chen, & Vernon W. Dolinsky. . (2015). Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes. The Journal of biological chemistry, 290, 10981–10993. PubMedPubMedCentral

92.

Han, D., Wang, Y., Wang, Y., Dai, X., Zhou, T., & Chen, J., et al. (2020). The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a. Circulation Research, 127, e108–e125. PubMed

93.

Zhang, T.L., J. Tong, Q., & Lin, L. (2020). SIRT3 Acts as a Positive Autophagy Regulator to Promote Lipid Mobilization in Adipocytes via Activating AMPK. Int J Mol Sci 21:372

94.

Na Yang, H. M., Jiang, Z., Niu, L., Zhang, X., Liu, Y., & Wang, Y., et al. (2019). Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress. Biochemical and Biophysical Research Communications, 517, 111–117. PubMed

95.

Dhingra, R., Guberman, M., Rabinovich-Nikitin, I., Gerstein, J., Margulets, V., & Gang, H., et al. (2019). Impaired NF-kappaB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvz240. CrossRefPubMed

96.

G, M., C, G., M, B., S, P., R, P., MR, W., G, C. and P, P. . (2015). Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. Journal of molecular and cellular cardiology, 78, 142–153.

97.

Castillo, E. C., & M.J., Chapoy-Villanueva H, Silva-Platas C, Treviño-Saldaña N, Guerrero-Beltrán CE, Bernal-Ramírez J, Torres-Quintanilla A, García N, Youker K, Torre-Amione G, & García-Rivas G. . (2019). Mitochondrial Hyperacetylation in the Failing Hearts of Obese Patients Mediated Partly by a Reduction in SIRT3: The Involvement of the Mitochondrial Permeability Transition Pore. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 53, 465–479.

98.

Verma, M., Shulga, N., & Pastorino, J. G. (2013). Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore. Biochimica et Biophysica Acta, 1827, 38–49. PubMed

99.

Zheng, Y., Shi, B., Ma, M., Wu, X., & Lin, X. (2019). The novel relationship between Sirt3 and autophagy in myocardial ischemia-reperfusion. Journal of Cellular Physiology, 234, 5488–5495. PubMed

100.

Li, J., Wang, P. Y., Long, N. A., Zhuang, J., Springer, D. A., & Zou, J., et al. (2019). p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Proc Natl Acad Sci U S A, 116, 19626–19634. PubMedPubMedCentral

101.

Lee, J., Kim, Y., Liu, T., Hwang, Y.J., Hyeon, S.J., Im, H., Lee, K., Alvarez, V.E., McKee, A.C., Um, S.J., Hur, M., Mook-Jung, I., Kowall, N.W. and Ryu, H. (2018). SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease. Aging Cell 17:12679

102.

Wei Li, Y. Y., Li, Y., Zhao, Y., & Jiang, H. (2019). Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2. BioMed Research International, 2019, 4745132. PubMed

103.

M, G., A, H., O, J. and H, M. . (2013). Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor. PLoS ONE, 8, e77713.

104.

Scher, M. B., Vaquero, A., & Reinberg, D. (2007). SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes & Development, 21, 920–928.

105.

Xiao, B., Hong, L., Cai, X., Mei, S., Zhang, P., & Shao, L. (2019). The true colors of autophagy in doxorubicin‑induced cardiotoxicity (Review). Oncology Letters. Doi: https://doi.org/10.3892/o1.2019.10576

106.

Li, M., Russo, M., Pirozzi, F., Tocchetti, C. G., & Ghigo, A. (2020). Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities. Biochim Biophys Acta Mol Cell Res, 1867, 118493. PubMed

107.

Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018). The Role of Autophagy in the Heart. Annual Review of Physiology, 80, 1–26. PubMed

108.

Kawaguchi, T., Takemura, G., Kanamori, H., Takeyama, T., Watanabe, T., & Morishita, K., et al. (2012). Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. Cardiovascular Research, 96, 456–465. PubMed

109.

Sishi, B. J., Loos, B., van Rooyen, J., & Engelbrecht, A. M. (2013). Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity. Biochemical Pharmacology, 85, 124–134. PubMed

110.

Dutta, D., Xu, J., Dirain, M. L. S., & Leeuwenburgh, C. (2014). Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free Radical Biology and Medicine, 74, 252–262. PubMed

111.

Lu, L., Wu, W., Yan, J., Li, X., Yu, H., & Yu, X. (2009). Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. International Journal of Cardiology, 134, 82–90. PubMed

112.

Lee, I. H. (2019). Mechanisms and disease implications of sirtuin-mediated autophagic regulation. Experimental & Molecular Medicine, 51, 1–11.

113.

Liu, G. Y., & Sabatini, D. M. (2020). mTOR at the nexus of nutrition, growth, ageing and disease. Nature Reviews Molecular Cell Biology, 21, 183–203. PubMed

114.

Yang, Y., Li, Na., Chen, T., Zhang, C. L., Jingyuan, L., & L., Qi, Y., Zheng, X., Zhang, C. and Bu, P. . (2019). Sirt3 promotes sensitivity to sunitinib-induced cardiotoxicity via inhibition of GTSP1/JNK/autophagy pathway in vivo and in vitro. Archives of Toxicology, 93, 3249–3260. PubMed

115.

Zheng, D., Zhang, Y., Zheng, M., Cao, T., Wang, G., & Zhang, L., et al. (2019). Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity. Clin Sci (Lond), 133, 1505–1521.

116.

Coelho, A. R., Martins, T. R., Couto, R., Deus, C., Pereira, C. V., & Simoes, R. F., et al. (2017). Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochim Biophys Acta Mol Basis Dis, 1863, 2904–2923. PubMed

117.

Hosseini, S. (2017). Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review. Journal of pharmacopuncture, 20, 243–256. PubMedPubMedCentral

118.

Pillai, V. B., & A.K., Yong Hu Fang, Willard W. Sharp, Sadhana Samant, Jack Arbiser, & Mahesh P. Gupta. . (2017). Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget, 21, 34082–34098.

119.

Parodi-Rullan, R. M., Chapa-Dubocq, X. R., & Javadov, S. (2018). Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3. Front Physiol, 9, 1094. PubMedPubMedCentral

120.

Lou, Y., Wang, Z., Xu, Y., Zhou, P., Cao, J., & Li, Y., et al. (2015). Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. International Journal of Molecular Medicine, 36, 873–880. PubMed

121.

Zhang, C., Feng, Y., Qu, S., Wei, X., Zhu, H., & Luo, Q., et al. (2011). Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovascular Research, 90, 538–545. PubMed

122.

Ortiz, K. V., Pérez-Vázquez, V., & Macías-Cervantes, M. H. (2019). Exercise and Sirtuins: A Way to Mitochondrial Health in Skeletal Muscle. International Journal of Molecular Sciences, 20, 2717.

123.

Marques Aleixo, I.S.-A., Mariani, E., & D., Rizo-Roca, D., Padrao, A.I., Rocha-Rodrigues, S., Viscor, G., Torrella, J.R., Ferreira, R., Oliveira, P.J., Magalhaes, J. and Ascensao, A. . (2015). Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress. Mitochondrion, 20, 22–33. PubMed

124.

JG, W., B, S., PC, W., DA, H., L, B., M, G., M, L., E, V. and SL, H. . (2018). Drosophila melanogasterSirt4 is a mitochondrial regulator of metabolism and lifespan in. Proceedings of the National Academy of Sciences of the United States of America, 115, 1564–1569.

Titel: Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
Autoren:: Ling He
Fuxiang Liu
Juxiang Li
Publikationsdatum: 12.01.2021
DOI: https://doi.org/10.1007/s12012-020-09626-x
Verlag: Springer US
Zeitschrift: Cardiovascular Toxicology
Ausgabe 3/2021
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259

Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Springer Medizin

Publisher's Note

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Innere Medizin

Weitere Artikel der Ausgabe 3/2021

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia

Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity

Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs

Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications